CMOS-based low-power, low-noise potentiostat circuit and its integration with an ENFM-based glucose sensor
11571148 · 2023-02-07
Assignee
Inventors
- Kavyashree Puttananjegowda (Tampa, FL, US)
- Sylvia Thomas (Orlando, FL, US)
- Arash Takshi (Tampa, FL, US)
Cpc classification
A61B5/1486
HUMAN NECESSITIES
G01N27/3271
PHYSICS
A61B5/14532
HUMAN NECESSITIES
A61B5/1468
HUMAN NECESSITIES
G01N27/3272
PHYSICS
A61B5/72
HUMAN NECESSITIES
G01N2333/904
PHYSICS
A61B2562/125
HUMAN NECESSITIES
International classification
C12Q1/00
CHEMISTRY; METALLURGY
A61B5/1486
HUMAN NECESSITIES
A61B5/145
HUMAN NECESSITIES
A61B5/1468
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
Abstract
The present disclosure presents glucose sensing methods and systems. One such system comprises an electrospun-nanofibrous-membrane (ENFM)-based amperometric glucose sensor integrated on a silicon chip, in which the glucose sensor has a working electrode, a reference electrode, and a counter electrode, wherein the working electrode comprises an ENFM-based sensing electrode. The system further comprises a potentiostat circuit integrated on the silicon chip such that the potentiostat circuit comprises a voltage control unit to control a voltage difference between the working electrode and the reference electrode and a transimpedance amplifier to measure a current flow between the working electrode and the counter electrode, in which a strength of the current flow corresponds to an amount of glucose present in a sample of blood on the glucose sensor.
Claims
1. A glucose sensor system comprising: an electrospun-nanofibrous-membrane (ENFM)-based amperometric glucose sensor integrated on a silicon chip, the glucose sensor having a working electrode, a reference electrode, and a counter electrode, wherein the working electrode comprises an ENFM-based sensing electrode comprising glucose oxidase bound to nanofibers; and a potentiostat circuit integrated on the silicon chip and coupled to the glucose sensor on a single chip, wherein the potentiostat circuit comprises: a voltage control unit to control a voltage difference between the working electrode and the reference electrode; and a transimpedance amplifier to measure a current flow between the working electrode and the counter electrode, wherein a strength of the current flow corresponds to an amount of glucose present in a sample of blood on the glucose sensor.
2. The system of claim 1, wherein the potentiostat circuit is implemented using a difference-differential telescopic cascode common source amplifier configuration.
3. The system of claim 1, further comprising an analog to digital converter and a digital signal processing circuit, wherein the analog to digital converter and the digital signal processing circuit are integrated on the silicon chip.
4. The system of claim 1, wherein the reference electrode comprises an Ag/AgCl electrode and the counter electrode comprises a gold-coated electrode.
5. The system of claim 1, wherein the ENFM-based sensing electrode comprises PEDOT:PSS nanofibers.
6. The system of claim 1, wherein the potentiostat circuit is configured to detect an electrochemical current ranging from 200 nA to 20 μA from the working electrode.
7. The system of claim 1, wherein the potentiostat circuit is characterized by a power consumption of 225 μW.
8. The system of claim 1, wherein the potentiostat circuit is configured to detect an electrochemical current ranging from 200 nA to 20 μA from the working electrode.
9. The system of claim 1, the potentiostat circuit is configured to detect an electrochemical current ranging from 200 nA to 20 μA from the working electrode; and the potentiostat circuit is characterized by a power consumption of 225 μW.
10. A glucose sensing method comprising: applying a sample of blood to an electrospun-nanofibrous-membrane (ENFM)-based amperometric glucose sensor, wherein the glucose sensor is integrated on a silicon chip and coupled to a potentiostat circuit integrated on the silicon chip, the glucose sensor having a working electrode, a reference electrode, and a counter electrode, wherein the working electrode comprises an ENFM-based sensing electrode comprising glucose oxidase bound to nanofibers, wherein the potentiostat circuit comprises a voltage control unit to control a voltage difference between the working electrode and the reference electrode and a transimpedance amplifier to measure a current flow between the working electrode and the counter electrode; measuring the current flow between the working electrode and the counter electrode of the ENFM-based amperometric glucose sensor; and signaling an amount of glucose present in the sample of blood by converting a measured value of the current flow to a measurement of the amount of glucose present in the sample of blood.
11. The method of claim 10, wherein both the voltage control unit and the transimpedance amplifier are implemented using a difference-differential telescopic cascode common source amplifier configuration.
12. The method of claim 10, further comprising detecting an electrochemical current from the working electrode.
13. The method of claim 12, wherein the electrochemical current ranges from ranging from 200 nA to 20 μA.
14. The method of claim 10, further comprising integrating an analog to digital converter and an digital signal processing circuit on the silicon chip.
15. The method of claim 10, wherein the ENFM-based sensing electrode comprises PEDOT:PSS nanofibers.
16. The method of claim 10, wherein the potentiostat circuit is characterized by a power consumption of 225 μW.
17. The method of claim 10, wherein the potentiostat circuit is configured to detect an electrochemical current ranging from 200 nA to 20 μA from the working electrode; and the potentiostat circuit is characterized by a power consumption of 225 μW.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.
(2)
(3)
(4) FIC. 1C is a bottom-view diagram of the first electrochemical ENFM-based glucose sensor of
(5)
(6)
(7) FIC. 1F is a bottom-view diagram of the second electrochemical ENFM-based glucose sensor of
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
DETAILED DESCRIPTION
(19) In accordance with the present disclosure, embodiments of a glucose sensing method and a glucose sensor system with a CMOS-based low-power, low-noise potentiostat circuit and an electrospun-nanofibrous-membrane (ENFM)-based amperometric glucose sensor on a single silicon chip are presented. In one embodiment, the glucose sensor can detect electrochemical current ranging from 200 nA to 20 μA from a working electrode with a high degree of linearity and the current depends on glucose concentration in the blood. Accordingly, a value of the glucose concentration in the blood can be determined or calculated from a measured current flow in the working electrode.
(20) An exemplary potentiostat, in accordance with embodiments of the present disclosure, includes both a voltage control unit (VCU) and a transimpedance amplifier (TIA), where both VCU and TIA are implemented using a difference-differential telescopic cascode common source amplifier configuration. This type of configuration achieves low-noise, high gain, and stability with significantly lower-power compared to existing potentiostats.
(21) Accordingly, in one embodiment, the present disclosure presents a low-voltage, low-noise, low-power and highly integrated 180 nm CMOS potentiostat with a miniaturized electrospun-nanofibrous-membrane (ENFM)-based amperometric glucose sensor on a single chip. Simulation results confirm the circuit operation with a low supply voltage of 1.4 V and demonstrate a power consumption of 225 μW.
(22) An exemplary potentiostat sensing system, in accordance with embodiments of the present disclosure, achieves competitive performance in terms of low-noise, high gain and increased linearity & stability with a significantly lower-power compared to prior state-of-the-art potentiostats. As shown in
(23) In general, the fabrication of an electrospun conducting polymer of a PEDOT:PSS nanofiber-based glucose sensor involves the following process steps, which are represented in
(24) Approach 1
(25) As shown in
(26) Approach 2
(27) In an additional embodiment, the fabrication of an electrospun conducting polymer of PEDOT:PSS nanofiber based glucose sensor involves the following process steps, which are represented in
(28) The counter electrode (CE) and the working electrode (WE) regions are patterned by photolithography and the sputtered gold layer is etched. Then, the photoresist is stripped to form CE and WE electrodes, as shown in
(29) Scanning electron microscope (SEM), transmission electron microscope (TEM), and atomic force microscope (AFM) (tapping mode) pictures of the fabricated polymer-based ENFM are shown in
(30)
(31) During testing, electrochemical measurements were performed on VersaSTAT-4 by Princeton Applied Research (PAR) with the three-electrode test setup with the ENFM electrode of surface area 0.35 cm×0.5 cm as the working electrode (WE), Ag/AgCl as the reference electrode (RE), and a bare gold electrode as the counter electrode (CE). The electrocatalytic activity of the working electrode was evaluated using chronoamperometry for various glucose concentrations and the current response was recorded for 160 seconds, as shown in
(32) Next, the electrochemical impedance spectroscopy (EIS) measurements were performed for an exemplary ENFM-based glucose sensing electrode. Accordingly, a Nyquist plot and an equivalent circuit model of the ENFM electrode were analyzed in 5 mM of electrolyte (potassium ferricyanide+glucose) solution within a frequency range of 100 mHz-10 kHz at an amplitude of 10 mV, as shown in
(33) The potentiostat circuit connected to the electrochemical cell utilizes a three electrode system which includes an RE, CE, and WE for amperometric measurements, in accordance with embodiments of the present disclosure. While a consistent potential is maintained between the working (WE) and the reference (RE) electrodes, an electrochemical reaction happens at the WE which is functionalized with the enzyme, in which the CE provides a path for the sensing current to the grounded WE and the current through the cell is controlled by the VCU so that the reference electrode is at the fixed potential throughout the reaction.
(34) Accordingly,
(35) For example, an exemplary difference-differential telescopic cascode TIA circuit is represented in
(36) The difference-differential telescopic cascode TIA amplifies the difference between two signals and rejects any common signals to the two input terminals (I.sub.in1 and I.sub.in2). The circuit is shown with inputs I.sub.in1 and I.sub.in2. To analyze the circuit, we will use superposition and virtual short concepts. Accordingly, if the input I.sub.in2=0, then there is no current in R.sub.4 and R.sub.5; therefore V.sub.2a=0. The resulting circuit acts as an inverting amplifier.
(37)
(38) If the input I.sub.in1=0, R.sub.4 and R.sub.5 form a voltage divider, since the current into the amplifier is zero. Therefore,
(39)
(40) From the virtual short concept, V.sub.1a=V.sub.2a and the circuit becomes a non-inverting amplifier, for which
(41)
(42) Substituting Equation (2) into Equation (3), we obtain Equation (4):
(43)
(44) Since the net output voltage is the sum of individual terms,
(45)
(46) If
(47)
I.sub.in1 & I.sub.in2≈I.sub.cell is the current across the resistor R.sub.1, and R.sub.1<<R.sub.f and R.sub.2, then
(48)
(49) Next, a small signal analysis is performed on the differential telescopic cascode configuration of
R.sub.out2=[(g.sub.m3,4r.sub.ds3,4+1)r.sub.ds1,2+r.sub.ds3,4]∥[(g.sub.m7,8r.sub.ds7,8+1)r.sub.ds5,6+r.sub.ds7,8)]
R.sub.out2=(g.sub.m3,4r.sub.ds3,4r.sub.ds1,2)∥(g.sub.m7,8r.sub.ds7,8r.sub.ds5,6) (8)
(50) The open loop gain can be calculated from differential inputs (V.sub.in1−V.sub.in2) to the single-ended output V.sub.2, as shown in Equation (9):
(51)
(52) To find the total gain of the amplifier from V.sub.in to V.sub.out, we need to consider a common source amplifier and the source follower gain. The common source amplifier gain is given in Equation (11) and source follower gain is given in Equation (12).
A.sub.V3=−g.sub.m9(r.sub.ds9∥r.sub.ds10) (10)
(53)
(54) If we substitute Equation (9), (11) and (12) in Equation (13) below, the total open loop gain of the differential telescopic cascode amplifier becomes:
(55)
(56) Let's consider the noise analysis of an exemplary differential telescopic cascode amplifier, as shown in
(57)
where K.sub.N and K.sub.P denote the 1/f noise coefficients of NMOS and PMOS transistors, f is the frequency, g.sub.m is the transconductance, W and L are the channel width and length of MOS transistors, C.sub.ox is the gate capacitance.
(58) The differential telescopic cascode amplifier input-referred voltage noise can be minimized by increasing the transconductance g.sub.m of transistors. When the transistor operates in saturation region, the equation for g.sub.m is given as follows:
(59)
To minimize the input-referred voltage noise, g.sub.m should be higher by making transistor wider which results in the smallest noise.
(60) The VCU utilizes a high gain amplifier to maintain a constant voltage difference by regulating the current, and the TIA has a low-noise and high gain to satisfy the output voltage swing for the maximum electrochemical current of 20 μA.
(61) In accordance with embodiments of the present disclosure, the VCU and TIA in the potentiostat are designed using a differential telescopic cascode amplifier topology, which has a 92 dB open loop gain and 77° phase margin with approximately 10 kHz bandwidth.
(62) Next,
(63) TABLE-US-00001 TABLE 1 (COMPARISON OF CMOS-BASED POTENTIOSTAT PERFORMANCE WITH PRIOR STATE-OF-THE-ART POTENTIOSTATS) Exemplary Gas Potentiostat Applications Biosensor Biosensor Biosensor Biosensor Biosensor Biosensor sensor Biosensor Technology CMOS CMOS CMOS CMOS CMOS CMOS CMOS CMOS 350 nm 350 nm 350 nm 350 nm 0.5 pm 180 nm 0.5 180 nm pm Sensing ISFET Micro Pt-nanoS 3D gold Nanopore MEA RTIL ENFM Electrode needle arrays Input Current −100 μA- 5 μA- −20 μA - 24 pA- −10 pA- 200 pA - 127 nA- 200 nA- Range 100 μA 30 μA 20 μA 0.35 μA 10 pA 50 nA 16 μA 20 μA Power 9.9 mW 5.1 mW 9.3 mW 0.188 mW 380 pW 3.21 mW 241 μW 225 μW Consumption Supply 3.3 V 1.65 V 3.3 V 3.3V 3.3V 1.8 V 5 V 1.4 V Voltage Input 150 pA/ 0.14 μA/ 0.47 pA/ 3.1 pA/ 3 pA/ 0.48 pA/ 3.1 pA/ 52.2 fA/ Referred √Hz √Hz √Hz √Hz √Hz √Hz √Hz √Hz Noise Current
(64) In accordance with various embodiments of the present disclosure, a CMOS potentiostat circuit has been integrated with an ENFM-based amperometric glucose sensor on a single chip. Such a fully integrated CMOS-based potentiostat demonstrates improved performance in terms of low-voltage, low-noise, low-power consumption, high-gain, and miniaturized design. In one embodiment, an exemplary potentiostat includes both VCU and TIA which are designed using difference-differential telescopic cascode amplifier configuration and has been shown to consume 225 μW of power from a 1.4 V voltage supply. Such a difference-differential telescopic cascode amplifier shows a high gain of 92 dB, a better phase margin of 77° with a bandwidth of approximately 10 kHz, and an input-referred noise current of 52.2 fA/√Hz. In one embodiment, a fabricated enzyme immobilized ENFM-based sensing electrode demonstrates the limit of detection (LOD) of 2.3 μM and sensitivity of 10.22 μA/mM cm.sup.2 in a glucose solution and it can be reused for up to 50 days. These results provide the basis for utilizing this exemplary low-noise and low-power potentiostat circuit design for integrated biosensing applications, including glucose sensor systems and related methods.
(65) It should be emphasized that the above-described embodiments of the present disclosure are merely possible examples of implementations, merely set forth for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiment(s) without departing substantially from the principles of the disclosure. All such modifications and variations are intended to be included herein within the scope of this disclosure and protected by the following claims.